Atlas Trials

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Clinical trial NCT06449833 · RECRUITING

Trial details

NCT number
NCT06449833
Sponsor
Zhujiang Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Start date
2024-06-01
Primary completion
2026-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.